Novel Signatures Based on the Lymphocyte-to-C-Reactive Protein Ratio Predict the Prognosis of Patients with Early Breast Cancer: A Retrospective Study.
Li WangYu-Ling ZhangChang JiangFang-Fang DuanZhong-Yu YuanJia-Jia HuangXi-Wen BiPublished in: Journal of inflammation research (2022)
The LCR was a significant prognostic predictor of OS and DFS in early BC. The LCR-based prognostic signatures could be a useful tool for individualized therapeutic guidance.